These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11810836)

  • 1. How should HIV patients lower lipid levels?
    Brown BR
    HIV Clin; 2000; 12(3):1, 6-8. PubMed ID: 11810836
    [No Abstract]   [Full Text] [Related]  

  • 2. Basic lipids: NCEP made easy for HIV patients.
    Cofrancesco J; Berkenblit G
    Hopkins HIV Rep; 2003 Sep; 15(5):10, 12. PubMed ID: 14686294
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Behrens GM
    N Engl J Med; 2005 Apr; 352(16):1721-2; author reply 1721-2. PubMed ID: 15843678
    [No Abstract]   [Full Text] [Related]  

  • 4. [KLAS [Kanazawa Lipid Assessment Survey]].
    Mabuchi H; Inazu A; Higashikata T; Nohara A; Koizumi J
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():469-76. PubMed ID: 11347115
    [No Abstract]   [Full Text] [Related]  

  • 5. [Helsinki Heart Study].
    Sekiya M; Ishibashi S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():404-9. PubMed ID: 11347103
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular manifestations of HIV infection.
    Ho JE; Hsue PY
    Heart; 2009 Jul; 95(14):1193-202. PubMed ID: 19564432
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications of 4S evidence on baseline lipid levels.
    Durrington PN
    Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7661979
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipid lowering therapy in patients with HIV infection.
    Wierzbicki AS; Reynolds TM; Crook MA; Tatler J; Peters BS
    Lancet; 1998 Nov; 352(9142):1782. PubMed ID: 9848376
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
    Dobordzhginidze LM
    Kardiologiia; 2004; 44(3):87-93. PubMed ID: 15489838
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing cardiovascular risk in patients with HIV infection.
    Stein JH
    J Acquir Immune Defic Syndr; 2005 Feb; 38(2):115-23. PubMed ID: 15671795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More Nuanced Guidelines for Lipid Lowering to Prevent CVD.
    Shaughnessy AF
    Am Fam Physician; 2016 Jan; 93(1):59. PubMed ID: 26760843
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical significance of treatment-induced lipid abnormalities and lipodystrophy.
    Smith D
    J HIV Ther; 2001 May; 6(2):25-7. PubMed ID: 11501199
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid-lowering drugs and changes to diet can make a difference.
    TreatmentUpdate; 2001 Aug; 13(4):7-9. PubMed ID: 11590981
    [No Abstract]   [Full Text] [Related]  

  • 14. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology).
    Esselstyn CB
    Am J Cardiol; 1999 Aug; 84(3):339-41, A8. PubMed ID: 10496449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fenofibrate].
    Yamashita T; Nakamura H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():618-24. PubMed ID: 11347142
    [No Abstract]   [Full Text] [Related]  

  • 16. A symposium: lipid management summit on improving practice outcome. Introduction.
    Ballantyne CM
    Am J Cardiol; 2000 Feb; 85(3A):1A-2A. PubMed ID: 10695700
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001.
    Bonnet F; Balestre E; Thiébaut R; Mercié P; Dupon M; Morlat P; Dabis F;
    HIV Med; 2004 May; 5(3):133-9. PubMed ID: 15139977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niacin as a component of combination therapy for dyslipidemia.
    Miller M
    Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statins (HMG-CoA reductase inhibitors)].
    Gotoda T
    Nihon Rinsho; 2006 Nov; 64(11):2113-8. PubMed ID: 17087305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease risk in pediatric HIV: the need for population-specific guidelines.
    Ross AC; McComsey GA
    J Acquir Immune Defic Syndr; 2011 Aug; 57(5):351-4. PubMed ID: 21694605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.